Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Na He, Linbiao Xiang, Lei Chen, Haobin Tong, Keshen Wang, Jie Zhao, Feixue Song, Hanteng Yang, Xinyuan Wei & Zuoyi Jiao. (2022) The role of long non-coding RNA FGD5-AS1 in cancer. Bioengineered 13:4, pages 11026-11041.
Read now
Read now
Huixiong Wang, Xin Zhang, Xiaoting Chen, Shengbin Zhang, Zhelin Yun, Qiang Gao, Haitao Sheng & Junjie Wang. (2022) Long non-coding RNA placenta‑specific protein 2 regulates the chemosensitivity of cancer cells to cisplatin in hepatocellular carcinoma (HCC) by sponging microRNA-96 to upregulate X-linked inhibitor of apoptosis protein. Bioengineered 13:4, pages 10765-10773.
Read now
Read now
Articles from other publishers (9)
Saade Abdalkareem Jasim, Ali A. Majeed, Herlina Uinarni, Mohammed Alshuhri, Abdullah Ali Alzahrani, Abeer A. Ibrahim, Ahmed Alawadi, Noor K. Abed Al-Abadi, Yasser Fakri Mustafa & Batool Ali Ahmed. (2024) Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms. Pathology - Research and Practice 254, pages 155119.
Crossref
Crossref
Imene Arab, Jeongkwang Park, Jae-Joon Shin, Hyeung-Seob Shin, Kyoungho Suk & Won-Ha Lee. (2023) Macrophage lncRNAs in cancer development: Long-awaited therapeutic targets. Biochemical Pharmacology 218, pages 115890.
Crossref
Crossref
Yu Wang, Ran Zuo, Gengwei Huo, Zhiqiang Han, Yuchao He, Yi Luo, Liwei Chen, Guangtao Li, Jinfang Cui, Fuyi Zhu, Ping Yue, Dongqi Yuan, Yi Sun, Zhaoyue Li, Peng Chen & Hua Guo. (2023)
TWF1
induces autophagy and accelerates malignant phenotype in lung adenocarcinoma via inhibiting the
cAMP
signaling pathway
. The FASEB Journal 37:7.
Crossref
Crossref
Yuan Fang, XiaoLi Zhang, HanFei Huang & Zhong Zeng. (2023) The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Journal of Translational Medicine 21:1.
Crossref
Crossref
Nicola Mosca, Aniello Russo & Nicoletta Potenza. (2023) Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 24:10, pages 8886.
Crossref
Crossref
Mehrdad Hashemi, Sepideh Mirzaei, Mohammad Arad Zandieh, Sahar Rezaei, Amirabbas kakavand, Amir Dehghanpour, Negin Esmaeili, Azin Ghahremanzade, Hamidreza Saebfar, Hajar Heidari, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari & Kwang Seok Ahn. (2023) Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Progress in Biophysics and Molecular Biology 177, pages 207-228.
Crossref
Crossref
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida & Stavroula Baritaki. (2022) Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability. Drug Resistance Updates 65, pages 100866.
Crossref
Crossref
Xuehao Zhou, Xiang Ao, Zhaojun Jia, Yiwen Li, Shouxiang Kuang, Chengcheng Du, Jinyu Zhang, Jianxun Wang & Ying Liu. (2022) Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. Frontiers in Oncology 12.
Crossref
Crossref
Ming Liu & Jingwei Peng. (2022) FTX Regulated miR-153-3p/FOXR2 to Promote Cisplatin Resistance in Ovarian Cancer. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Crossref